These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6843753)

  • 1. Medium-sized peptides in the blood of patients with uremia.
    Mabuchi H; Nakahashi H
    Nephron; 1983; 33(4):232-7. PubMed ID: 6843753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of urinary medium-sized peptides in normal and uremic urine by high-performance liquid chromatography.
    Mabuchi H; Nakahashi H
    J Chromatogr; 1982 Dec; 233():107-13. PubMed ID: 7161326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatographic studies of uremic plasma.
    Mamdani BH; Shaykh MM; Evenson MA; Dunea G
    Int J Artif Organs; 1979 Jul; 2(4):187-91. PubMed ID: 88420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid composition of uremic middle and low molecular weight retention products.
    Bazilinski N; Shaykh M; Ahmed S; Musiala T; Williams RH; Poulos A; Dubin A; Dunea G
    Adv Exp Med Biol; 1987; 223():197-204. PubMed ID: 3447436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A uremic peptide containing polyamine: formation and possible role in uremic hypertriglyceridemia.
    Lutz W
    Physiol Chem Phys; 1980; 12(5):451-6. PubMed ID: 7010392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum.
    Bourgoignie J; Klahr S; Bricker NS
    J Clin Invest; 1971 Feb; 50(2):303-11. PubMed ID: 5540168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid-chromatographic study of fluorescent materials in uremic fluids.
    Swan JS; Kragten EY; Veening H
    Clin Chem; 1983 Jun; 29(6):1082-4. PubMed ID: 6851098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and analysis of plasmatic components of middle molecular weight in patients with uremic syndrome.
    Martín Mateo MC; Cuevas Lobato OL; Bustamante J
    Nephron; 1995; 71(2):160-7. PubMed ID: 8569948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating forms of glucagon and related peptides in normal subjects and uraemic patients.
    Flanagan RW; Murphy RF; Buchanan KD
    Biochem Soc Trans; 1980 Aug; 8(4):426-7. PubMed ID: 7450164
    [No Abstract]   [Full Text] [Related]  

  • 10. Bound amino acids in uremic sera: search for peptidic middle molecules by preparative polyacrylamide gel electrophoresis and high performance liquid chromatography.
    Kaplan B; Gotfried M; Cojocaru M; Pras M; Ravid M
    Clin Chim Acta; 1989 Nov; 185(2):119-30. PubMed ID: 2624993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of an immunosuppressive fraction in ultrafiltrate from uremic sera.
    Navarro J; Grossetete MC; Defrasne A; Touraine JL; Traeger J
    Nephron; 1985; 40(4):396-400. PubMed ID: 4022207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A gas chromatographic-mass spectrometric analysis of organic acids in uremic ultrafiltrate (author's transl)].
    Maeda K; Niwa T; Kobayashi K
    Nihon Jinzo Gakkai Shi; 1981 Jan; 23(1):75-88. PubMed ID: 7289205
    [No Abstract]   [Full Text] [Related]  

  • 13. [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia].
    Popławski A; Myśliwiec M
    Pol Merkur Lekarski; 1996 Oct; 1(4):246-8. PubMed ID: 9156935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients.
    Kikuchi T; Orita Y; Ando A; Mikami H; Fujii M; Okada A; Abe H
    Clin Chem; 1981 Nov; 27(11):1899-902. PubMed ID: 7296840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of plasma middle molecular fraction in uremic patients.
    Kovalishin YaF
    Biomater Artif Cells Artif Organs; 1987; 15(3):605-10. PubMed ID: 3440134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Many hitherto unknown peptides are principal constituents of uremic "middle molecules".
    Menyhárt J; Gróf J
    Clin Chem; 1981 Oct; 27(10):1712-6. PubMed ID: 7285323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
    Li G; Chu J; Liu X; Yuan Z
    Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid containing compounds in uremic serum-search for middle molecules by high performance liquid chromatography.
    Kaplan B; Gotfried M; Ravid M
    Clin Nephrol; 1986 Aug; 26(2):66-71. PubMed ID: 3757315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of endogenous middle molecules in normal and uremic body fluids.
    Fürst P; Zimmerman L; Bergström J
    Clin Nephrol; 1976 Apr; 3(2):178-88. PubMed ID: 1277595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of serum and ultrafiltrate (less than 50 k DA) of normal serum and uremic serum from chronic hemodialysis children on lipid peroxidation and vitality of fetal rat hepatocytes in vitro].
    Räder R; Otting U
    Z Urol Nephrol; 1990 Oct; 83(10):573-80. PubMed ID: 2095665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.